2027 Generic Medicines Framework Agreement

Summary

The Catalan Health Institute is procuring an aggregate supply of generic medicines for 2027 for its own centres and participating healthcare organisations under an 11-lot framework agreement. The lots cover medicines by route and type of presentation, including oral, parenteral, topical and inhaled medicines, cytotoxic medicines, unit-dose oral medicines, treprostinil, levonorgestrel, and medicines at risk of shortage. The estimated value is €180,105,586.60 excluding VAT; the initial term is 10 months, with possible extensions of up to 36 months.